VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
NATR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
NATRNature's Sunshine Products, Inc.
$10.87$191M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksNATRFinancials

Nature's Sunshine Products, Inc. (NATR) Income Statement

30Y historyFree accessUpdated daily

Revenue growth cooled to 1.9% in 2026Q2 despite the series-high 73.7% gross margin, while a 44% sequential decline in SG&A to $44.9M left operating margin at just 4.7% and diluted EPS down 32.1% at $0.19.

Income StatementBalance SheetCash FlowRatios

NATR Income Statement

Annual statement

NATR Income Statement

Nature's Sunshine Products, Inc. (NATR) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Sales/Revenue480.29M480.14M454.36M445.32M421.91M444.08M385.2M362.21M364.81M342.03M341.16M324.7M366.37M378.1M367.47M367.81M349.92M343.02M381.3M366.65M362.22M351.68M331.06M297.26M298.73M318.72M314.82M289.2M296.1M280.9M249M
Revenue Growth %1.21%5.67%2.03%5.55%-4.99%15.29%6.35%-0.71%6.66%0.26%5.07%-11.37%-3.1%2.89%-0.09%5.11%2.01%-10.04%4%1.22%3%6.23%11.37%-0.49%-6.27%1.24%8.86%-2.33%5.41%12.81%21.11%
Cost of Goods Sold129.4M132.42M129.68M124.19M122.15M115.47M101.28M93.94M95.69M91.04M90.94M85.34M91.58M94.81M93.32M69.41M69.04M68.8M71.87M71M68.75M67.59M62.69M51.93M53.32M57.66M48.52M45.1M47.4M47.3M41.5M
COGS % of Revenue-27.58%28.54%27.89%28.95%26%26.29%25.93%26.23%26.62%26.66%26.28%25%25.08%25.4%18.87%19.73%20.06%18.85%19.36%18.98%19.22%18.94%17.47%17.85%18.09%15.41%15.59%16.01%16.84%16.67%
Gross Profit350.89M347.72M324.69M321.13M299.76M328.62M283.93M268.27M269.12M250.99M250.22M239.36M274.78M283.28M274.14M298.4M280.88M274.22M309.43M295.65M293.48M284.09M268.37M245.34M245.42M261.06M266.3M244.1M248.7M233.6M207.5M
Gross Margin %73.06%72.42%71.46%72.11%71.05%74%73.71%74.07%73.77%73.38%73.34%73.72%75%74.92%74.6%81.13%80.27%79.94%81.15%80.64%81.02%80.78%81.06%82.53%82.15%81.91%84.59%84.41%83.99%83.16%83.33%
Gross Profit Growth %-7.09%1.11%7.13%-8.78%15.74%5.84%-0.31%7.22%0.31%4.54%-12.89%-3%3.33%-8.13%6.24%2.43%-11.38%4.66%0.74%3.3%5.86%9.39%-0.03%-5.99%-1.97%9.09%-1.85%6.46%12.58%21.63%
Operating Expenses325.26M322.98M304.59M302.38M283.5M293.95M262.45M252.15M263.77M249.6M240.18M225.49M255.74M259.23M240.13M278.24M269.62M263.45M303.83M292.59M285.47M272.51M246.72M237.63M233.75M237.16M239.67M217M212.6M202.6M181.1M
OpEx % of Revenue-67.27%67.04%67.9%67.19%66.19%68.13%69.61%72.3%72.98%70.4%69.44%69.8%68.56%65.35%75.65%77.05%76.8%79.68%79.8%78.81%77.49%74.52%79.94%78.25%74.41%76.13%75.03%71.8%72.13%72.73%
Selling, General & Admin252.08M322.98M304.59M302.38M283.5M293.95M262.45M252.15M263.77M249.6M240.18M225.49M255.74M259.23M240.13M278.24M269.62M263.45M303.83M148.71M139.65M128.38M246.72M198.57M233.75M237.16M232.74M210.9M207.8M198.3M177.7M
SG&A % of Revenue-67.27%67.04%67.9%67.19%66.19%68.13%69.61%72.3%72.98%70.4%69.44%69.8%68.56%65.35%75.65%77.05%76.8%79.68%40.56%38.55%36.5%74.52%66.8%78.25%74.41%73.93%72.93%70.18%70.59%71.37%
Research & Development001.7M01.5M0002.8M3.4M3.2M2.8M2.5M2M1.46M0000000000000000
R&D % of Revenue--0.37%-0.36%---0.77%0.99%0.94%0.86%0.68%0.53%0.4%----------------
Other Operating Expenses2M0-1.7M0-1.5M000-2.15M0-773K0-34K000000143.88M145.83M144.13M039.06M006.93M6.1M4.8M4.3M3.4M
Operating Income25.63M24.74M20.09M18.75M16.26M34.67M21.48M16.13M5.35M1.39M10.04M13.87M19.05M24.06M34.02M20.16M11.26M10.77M5.6M3.06M8.01M11.59M21.65M7.71M11.67M23.9M26.63M27.1M36.1M31M26.4M
Operating Margin %5.34%5.15%4.42%4.21%3.85%7.81%5.58%4.45%1.47%0.41%2.94%4.27%5.2%6.36%9.26%5.48%3.22%3.14%1.47%0.83%2.21%3.29%6.54%2.59%3.91%7.5%8.46%9.37%12.19%11.04%10.6%
Operating Income Growth %-23.13%7.18%15.32%-53.11%61.39%33.22%201.35%285.8%-86.18%-27.63%-27.17%-20.82%-29.28%68.69%79.04%4.61%92.34%82.88%-61.76%-30.9%-46.5%181%-33.96%-51.18%-10.25%-1.74%-24.93%16.45%17.42%50%
EBITDA35.58M38.59M34.31M30.57M27.26M45.83M32.23M26.72M15.16M10.02M14.85M18.4M23.46M28.52M38.09M24.53M15.52M15.27M11.04M-3.35M1.78M5.63M27.38M14.09M19.97M30.73M33.55M33.2M40.9M35.3M29.8M
EBITDA Margin %7.41%8.04%7.55%6.86%6.46%10.32%8.37%7.38%4.15%2.93%4.35%5.67%6.4%7.54%10.37%6.67%4.43%4.45%2.89%-0.91%0.49%1.6%8.27%4.74%6.68%9.64%10.66%11.48%13.81%12.57%11.97%
EBITDA Growth %-7.67%12.45%12.27%12.13%-40.53%42.23%20.58%76.31%51.25%-32.5%-19.3%-21.57%-17.76%-25.12%55.31%58.07%1.63%38.36%429.6%-287.98%-68.34%-79.45%94.28%-29.41%-35.02%-8.43%1.07%-18.83%15.86%18.46%41.23%
D&A (Non-Cash Add-back)9.83M13.84M14.22M11.82M11M11.16M10.74M10.6M9.81M8.63M4.81M4.53M4.41M4.47M4.08M4.36M4.25M4.5M5.44M-6.41M-6.22M-5.96M5.73M6.39M8.3M6.83M6.93M6.1M4.8M4.3M3.4M
EBIT24.52M29.91M18.57M20.27M15.46M32.07M22.92M15.69M3.59M1.39M10.04M17.18M21.25M25.81M35.62M22.1M13.99M14.45M6.52M4.53M9.24M12.15M21.65M7.71M11.67M23.9M26.63M27.1M36.1M31M26.4M
Net Interest Income151K547K31K483K-126K216K69K219K-387K-145K575K1.36M-187K605K1.28M1.38M270K1.32M1.78M1.34M710K91K464K1.25M1.05M1.66M1.92M000-100K
Interest Income296K645K177K552K123K466K171K262K0144K591K1.49M0836K1.46M1.47M270K1.41M1.83M1.41M1.32M821K568K1.52M1.09M1.67M1.94M0000
Interest Expense145K98K146K69K249K250K102K43K387K289K16K130K187K231K178K89K0124K52K69K609K730K104K268K39K4K20K000100K
Other Income/Expense-1.25M5.07M-1.67M1.45M-1.04M-2.85M1.34M-483K-2.15M1.83M-773K-592K-34K1.6M1.48M1.85M2.73M1.89M870K1.4M624K-162K1.31M-474K-972K1.44M1.29M1.9M2.3M2.2M1.4M
Pretax Income24.38M29.81M18.43M20.2M15.21M31.82M22.82M15.64M3.2M3.22M9.27M13.28M19.01M25.65M35.5M22.01M13.99M14.32M6.47M4.46M8.63M11.42M22.96M7.23M10.7M25.33M27.92M29M38.4M33.2M27.8M
Pretax Margin %5.08%6.21%4.06%4.54%3.61%7.17%5.92%4.32%0.88%0.94%2.72%4.09%5.19%6.78%9.66%5.98%4%4.18%1.7%1.22%2.38%3.25%6.94%2.43%3.58%7.95%8.87%10.03%12.97%11.82%11.16%
Income Tax9.32M9.36M10.53M3.79M14.66M1.61M-137K8.71M4.4M17.04M8.59M1.74M-743K8.04M10.12M4.41M5.52M8.21M8.31M12.7M12.19M7.92M5.88M2.13M3.63M8.67M10.79M11.2M15.1M13.1M11M
Effective Tax Rate %38.22%31.4%57.17%18.74%96.39%5.08%-0.6%55.7%137.56%528.83%92.72%13.1%-3.91%31.36%28.5%20.04%39.46%57.31%128.42%284.48%141.31%69.33%25.62%29.49%33.96%34.24%38.64%38.62%39.32%39.46%39.57%
Net Income14.65M19.52M7.7M15.08M-390K28.85M21.34M6.76M-854K-12.94M2.14M14.69M10.02M17.61M25.38M17.6M-1.23M6.12M-1.84M-8.24M-3.56M3.5M17.08M5.1M7.06M16.66M17.13M17.8M23.3M20.1M16.8M
Net Margin %3.05%4.07%1.69%3.39%-0.09%6.5%5.54%1.87%-0.23%-3.78%0.63%4.52%2.73%4.66%6.91%4.79%-0.35%1.78%-0.48%-2.25%-0.98%1%5.16%1.72%2.36%5.23%5.44%6.15%7.87%7.16%6.75%
Net Income Growth %-2.92%153.65%-48.95%3965.64%-101.35%35.23%215.4%892.15%93.4%-705.05%-85.44%46.59%-43.1%-30.62%44.2%1527.49%-120.16%432.7%77.69%-131.05%-201.74%-79.48%234.93%-27.82%-57.6%-2.76%-3.76%-23.61%15.92%19.64%41.18%
Net Income (Continuing)15.06M20.45M7.89M16.42M550K30.21M22.96M6.93M-1.2M-13.82M675K11.54M19.76M17.65M25.38M17.6M8.47M6.55M-1.84M-8.24M-3.56M3.5M17.08M5.1M7.06M16.66M17.13M17.8M23.3M20.1M16.8M
Discontinued Operations000000000002.12M0000000000000000000
Minority Interest005.68M5.48M4.14M3.2M1.85M227K63K411K1.29M2.75M3.78M000000000000000000
EPS (Diluted)0.821.060.400.77-0.021.421.070.34-0.04-0.690.110.770.561.071.591.12-0.080.39-0.12-0.53-0.230.231.100.360.430.991.021.001.251.060.86
EPS Growth %0.86%165%-48.05%3950%-101.41%32.71%214.71%860.63%93.52%-727.27%-85.71%37.5%-47.66%-32.7%41.96%1517.72%-120.26%425%77.36%-130.43%-200%-79.09%205.56%-16.28%-56.57%-2.94%2%-20%17.92%23.26%36.51%
EPS (Basic)-1.080.410.79-0.021.451.090.35-0.04-0.690.110.790.581.101.621.13-0.080.39-0.12-0.53-0.230.231.140.360.451.021.021.011.271.080.86
Diluted Shares Outstanding17.87M18.47M18.62M19.47M19.33M20.33M19.97M19.66M19.12M18.88M19.06M19.18M17.64M16.39M15.99M15.7M15.61M15.51M15.51M15.49M15.34M15.52M15.48M14.16M16.43M16.83M16.8M17.8M18.64M18.96M19.68M
Basic Shares Outstanding17.52M18M18.62M19.07M19.33M19.86M19.54M19.31M19.12M18.76M18.73M18.66M17.11M16M15.65M15.55M15.52M15.51M15.51M15.49M15.34M15.21M14.92M14.16M15.7M16.33M16.8M17.62M18.35M18.61M19.68M
Dividend Payout Ratio-----68.82%----351.05%51%351.61%172.75%9.26%--12.69%---87.13%17.57%37.09%29.88%13.03%13.12%12.92%10.73%12.44%14.88%

Key Metrics

Growth RegimeMixed
ProfitabilityModerate
Balance SheetAdequate
Cash FlowStable
Top Statement Risk

SG&A volatility distorting earnings

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Revenue Growth Uneven Across Channels

NATR's quarterly revenue growth has swung between -5.1% and 12.0% over the past ten quarters, with the most recent quarter decelerating to 1.9% growth, suggesting demand momentum is inconsistent and may be tied to promotional or channel-specific dynamics rather than a durable volume trend.

The 12.0% surge in 2025Q3 followed by 4.7% and 8.5% sequential quarters shows NATR can post strong top-line results intermittently, but the 1.9% print in 2026Q2 warrants scrutiny as to whether prior strength was pulled forward or driven by one-time distributor activity. The absence of a clear accelerating trajectory — with several quarters printing near-flat growth — suggests NATR is operating in a mature, low-growth category where share gains are episodic rather than structural.

Gross Margin Expansion Drives Profitability

NATR's gross margin has steadily expanded from 71.2% in 2024Q1 to 73.7% in 2026Q2, a 250-basis-point improvement that places it mid-range among direct-selling peers and reflects favorable product mix or cost discipline rather than a step-function pricing event.

The consistent upward drift in gross margin — never dipping below 71.2% in any reported quarter — indicates NATR is managing its supply chain and product mix effectively, which is a meaningful structural positive for a packaged-supplements manufacturer. However, the improvement appears gradual rather than dramatic, suggesting the driver is incremental cost control or modest price realization rather than a meaningful repositioning of the product portfolio. Investors should assess whether this margin trajectory is sustainable as input cost pressures evolve.

SG&A Volatility Distorts Operating Leverage Read

SG&A expenses plunged from $80.4M in 2026Q1 to just $44.9M in 2026Q2 — a 44% sequential decline — while revenue fell only 4.8%, implying a significant shift in expense recognition that materially inflated the quarter's operating margin optics and warrants careful normalization.

The sharp SG&A compression in 2026Q2 is highly unusual for a company of this size and suggests either a restructuring charge in the prior quarter, a change in accounting classification, or a timing-driven reversal — the data provided does not allow us to identify which. Excluding this anomaly, NATR's more typical SG&A run-rate of $73–85M leaves operating margins in the 3.8–7.8% range, which is broadly in line with USANA's 5.5% but meaningfully below Nu Skin's 6.1%. The structural operating leverage question remains open: gross profit grew from $79M to $94M over the period, yet operating income has not scaled proportionally due to persistent overhead absorption.

EPS Swings Reflect Underlying Earnings Instability

NATR's diluted EPS swung from -$0.02 in 2024Q4 to $0.30 in 2025Q3 before settling at $0.19 in 2026Q2, a range of outcomes that reflects genuine operating volatility rather than accounting-driven distortions, though the -32.1% EPS decline in the latest quarter against 1.9% revenue growth signals margin compression at the bottom line.

The 2024Q4 net loss of -$0.02 per share occurred despite $4.5M in operating income, implying significant below-the-line charges — likely tax or non-operating items — that depressed the result. More recently, the 3.0% net margin in 2026Q2 is notably below the 4.2% average seen in prior quarters, which may indicate rising tax rates or unusual items that should be tracked in subsequent filings. The negative SBC figure of -$4.2M in 2025Q4 is also unusual and suggests a reversal or true-up event that temporarily inflated reported earnings, adding noise to any trailing EPS trend analysis.

Sustainability Questions Surround Margin Story

NATR's recent profitability improvements may be fragile given that its 4.7% operating margin in 2026Q2 — the lowest since 2024Q4 — arrived despite the highest gross margin in the series at 73.7%, suggesting the gross-line gains are being offset by underlying cost pressures that could intensify if revenue growth continues to decelerate.

A short-seller would likely focus on the inconsistency: gross margins keep expanding, yet operating and net margins have not structurally improved, indicating that the company's expense base is absorbing the gains. The 2026Q2 SG&A anomaly creates an optics problem — the quarter looks like a margin recovery on paper, but the underlying $44.9M SG&A figure may not be representative of the true cost base. Additionally, NATR's 3.0% net margin compares unfavorably to Nu Skin's 10.8%, and even USANA's 1.2% net margin suggests the entire direct-selling peer group is under margin pressure; NATR's position is defensible but not structurally advantaged.

2025 Inflection Set New Baseline for Growth

The operational inflection appears to have occurred in 2025Q1–Q3, when revenue growth accelerated from the 2–3% range to 12.0% and operating margins peaked at 7.0%, establishing a new revenue baseline above $113M per quarter that has persisted into 2026 even as growth rates normalized.

Prior to 2025, NATR was posting low-single-digit growth with operating margins near 4–5%; the 2025 step-up — driven by what appears to be either a successful product launch, channel expansion, or distributor recruitment cycle — established a higher revenue floor. The lasting impact is that NATR's gross profit base is now structurally higher at $86–94M per quarter versus $79–85M in 2024, which provides more absolute dollars to fund operating expenses. However, the durability of this inflection depends on whether the 2026 deceleration to 1.9% growth represents a return to the pre-2025 trend or a temporary pause, a distinction that should clarify over the next few reporting periods.

NATR — Frequently Asked Questions

Quick answers to the most common questions about buying NATR stock.

What was Nature's Sunshine Products, Inc.'s (NATR) revenue in 2025?

For fiscal year 2025, Nature's Sunshine Products, Inc. (NATR) reported total revenue of $480.1M. This represents a 92.8% increase compared to $249.0M in 1996.

Is Nature's Sunshine Products, Inc. (NATR) profitable?

Nature's Sunshine Products, Inc. (NATR) is profitable, generating $19.5M in net income for the fiscal year ending 2025 with a net profit margin of 4.1%.

What is Nature's Sunshine Products, Inc.'s operating profit margin?

Nature's Sunshine Products, Inc. (NATR) reported an operating income of $24.7M, resulting in an operating profit margin of 5.2%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Nature's Sunshine Products, Inc.'s gross profit and gross margin?

Nature's Sunshine Products, Inc. (NATR) generated $347.7M in gross profit for the year, representing a gross profit margin of 72.4%. This demonstrates the company's core pricing power and production efficiency.